Proteomics

Dataset Information

0

A peptide-based tolerizing vaccine against autoimmune arthritis directly interacting with antigen-specific T cells


ABSTRACT: A longstanding goal has been to find an antigen-specific preventive therapy, i.e., a vaccine, for autoimmune diseases. Major hindrances have so far been to select natural regulatory antigen targets and side-effects induced by clustering the T cell receptor (TCR) or activating the costimulatory signals. Here we show that the administration of a mouse major histocompatibility complex class II protein binding a unique galactosylated collagen type II (COL2) peptide (Aq-galCOL2) directly interacts with the antigen specific TCR, and expands peripheral regulatory T cells, displaying a potent dominant suppressive effect and protection of collagen induced arthritis. The therapeutic effect is dominant and tissue specific as it is possible to transfer the effect with induced regulatory T cells and downregulate autoimmune arthritis induced by other antigens than COL2 or by passive transfer of antibodies. Thus, the here described tolerogenic approach may be a promising dominant antigen-specific therapy for RA, and in principle, for autoimmune diseases in general.

INSTRUMENT(S): Orbitrap Fusion Lumos

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Primary Cell, T Cell

SUBMITTER: Christian Beusch  

LAB HEAD: Rikard Holmdahl

PROVIDER: PXD034792 | Pride | 2023-06-15

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
210326_VU_fraction10.raw Raw
210326_VU_fraction11.raw Raw
210326_VU_fraction12.raw Raw
210326_VU_fraction4.raw Raw
210326_VU_fraction5.raw Raw
Items per page:
1 - 5 of 13

Similar Datasets

2020-09-28 | PXD019876 | Pride
2023-12-31 | GSE205501 | GEO
| phs001082 | dbGaP
2015-12-10 | PXD002644 | Pride
2015-12-11 | PXD003183 | Pride
2015-12-10 | PXD002643 | Pride
2021-07-15 | PXD024126 | Pride
2019-07-30 | GSE122894 | GEO
2019-05-01 | GSE129511 | GEO
2008-06-12 | E-GEOD-3997 | biostudies-arrayexpress